Sammibi

Sammibi is a radioactive medicine used to create images of your heart, breasts, or parathyroid glands to help doctors diagnose conditions.

Form
valmisteyhdistelmä radioaktiivista lääkettä varten
Strength
1 mg
Active Ingredient
Tetrakis (2-methoxy isobutyl isonitrile) copper (I) tetrafluoroborate
Manufacturer
Narodowe Centrum Badán Jadrowych

How to Use

Dosage

Your doctor will decide the exact dose you need, which is the smallest amount required for the examination. For adults, the usual dose is between 200 and 2000 MBq. For children and teenagers, the dose is based on their weight.

Method

Sammibi is given as an injection into a vein in your arm or foot. You may receive one or two injections, depending on the examination. You will be asked to drink fluids and urinate often after the injection.

Important

The maximum daily dose for heart studies is 2000 MBq if given on the same day.

Possible Side Effects

COMMON
  • Metallic or bitter taste in mouth
  • Altered sense of smell
  • Dry mouth immediately after injection
RARE
  • Headache
  • Chest pain
  • Abnormal EKG (heart tracing)
  • Nausea (feeling sick)
  • Abnormal heart rhythm
  • Local reactions at the injection site
  • Abdominal pain
  • Fever
  • Fainting
  • Seizures
  • Dizziness
  • Redness of skin
  • Numbness or tingling sensation in the skin
  • Tiredness
  • Joint pain
  • Upset stomach (indigestion)
  • Erythema multiforme (skin rash)
  • Widespread skin and mucous membrane rash

Important Warnings

  • Do not use Sammibi if you are allergic to it or any of its ingredients.
  • Tell your doctor if you are pregnant, think you might be pregnant, or are breastfeeding.
  • Inform your doctor if you have kidney or liver disease.
  • If you are having a heart scan, you must not eat for at least 4 hours before the procedure.
  • Drink plenty of water before the examination and for several hours afterward to help the medicine leave your body faster.
Show 2 more warnings
  • If you are under 18, discuss this with your doctor.
  • Avoid close contact with young children and pregnant women for 24 hours after the injection.